The tautomerase activity of tumor exosomal MIF promotes pancreatic cancer progression by modulating MDSC differentiation.
Xuebing JiaJianbei XiBinle TianYuanyuan ZhangZhilong WangFan WangZheng LiJiang LongJian-Fei WangGuo-Huang FanQi LiPublished in: Cancer immunology research (2023)
Pancreatic cancer is a deadly disease that is largely resistant to immunotherapy, in part because of the accumulation of immunosuppressive cells in the tumor microenvironment (TME). Much evidence suggests that tumor-derived exosomes contribute to the immunosuppressive activity mediated by myeloid-derived suppressor cells (MDSCs) within the pancreatic cancer TME. However, the underlying mechanisms remain elusive. Herein, we report that macrophage migration inhibitory factor (MIF) in tumor-derived exosomes has a key role in inducing MDSC formation in pancreatic cancer. We identified MIF in both human and murine pancreatic cancer-derived exosomes. Upon specific shRNA-mediated knockdown of MIF, the ability of pancreatic cancer-derived exosomes to promote MDSC differentiation was abrogated. This phenotype was rescued by re-expression of the wildtype form of MIF rather than a tautomerase-null mutant or a thiol-protein oxidoreductase-null mutant, indicating that both MIF enzyme activity sites play a role in exosome-induced MDSC formation in pancreatic cancer. RNA sequencing data indicated that MIF tautomerase regulated the expression of genes required for MDSC differentiation, recruitment, and activation. We therefore developed a MIF tautomerase inhibitor, IPG1576. The inhibitor effectively inhibited exosome-induced MDSC differentiation in vitro and reduced tumor growth in an orthotopic pancreatic cancer model, which was associated with decreased numbers of MDSCs and increased infiltration of CD8+ T cells in the TME. Collectively, our findings highlight a pivotal role for MIF in exosome-induced MDSC differentiation in pancreatic cancer and underscore the potential of MIF tautomerase inhibitors to reverse the immunosuppressive pancreatic cancer microenvironment, thereby augmenting anticancer immune responses.
Keyphrases
- stem cells
- mesenchymal stem cells
- immune response
- poor prognosis
- induced apoptosis
- high glucose
- diabetic rats
- endothelial cells
- small molecule
- dna methylation
- signaling pathway
- inflammatory response
- cell proliferation
- binding protein
- artificial intelligence
- bone marrow
- cell death
- endoplasmic reticulum stress
- big data
- amino acid